RxDoctor Payments Data

Christine Mackie, MD

Family Medicine · Cape Coral, FLNPI 1437140126

Payments from drug & device makers

$493in general payments, 2019–2025

Across 11 payments — averaging $44.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$336
  • AbbVie$43
  • Abbott$43
  • AstraZeneca$32
  • Alkermes, Inc.$20
  • Lilly USA, LLC$19

What the payments were for

  • Travel & lodging$33668%
  • Food & beverage$15732%

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$493 in reported general payments places this provider in the 50th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$101,555
Medicare patients
267
Services billed
930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide97$116,011
EliquisApixaban72$78,857
MounjaroTirzepatide62$68,881
JanuviaSitagliptin Phosphate62$67,916
FarxigaDapagliflozin Propanediol50$60,747
JardianceEmpagliflozin37$44,802
RybelsusSemaglutide18$28,951
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$25,761
Breo ElliptaFluticasone/Vilanterol35$16,049
Repatha SureclickEvolocumab21$14,152
SymbicortBudesonide/Formoterol Fumarate34$10,930
Dexlansoprazole DrDexlansoprazole31$10,187
MyrbetriqMirabegron12$8,003
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$7,660
Lantus SolostarInsulin Glargine,hum.Rec.Anlog49$5,127

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$32$71,67784 claims
Lilly USA, LLCMounjaro$19$68,88162 claims
AbbVieSynthroid$43$4,37468 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Cape Coral

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →